Citadel Advisors »

Inmed Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.2k 12k 0.27
2024-03-31 $4.5k 13k 0.35
2023-12-31 $14k 34k 0.42

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Inmed Pharmaceuticals

Virtu Financial
Baader Bank
XTX Topco
Hrt Financial
Citadel Advisors
Qube Research & Technologies
Bank of America Corporation
TD Waterhouse Canada
Royal Bank of Canada
AllSquare Wealth Management
Global Retirement Partners
Toronto-Dominion Bank
Gables Capital Management

View all funds holding Inmed Pharmaceuticals